Cinacalcet
Top View
- Calcium-Sensing Receptor in Adipose Tissue: Possible Association with Obesity-Related Elevated Autophagy
- Cinacalcet Plus Vitamin D Versus Vitamin D Alone for the Treatment Of
- KDIGO 2017 Clinical Practice Guideline Update for the Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease–Mineral and Bone Disorder (CKD-MBD)
- Osteoporosis in Patients with Chronic Kidney Diseases: a Systemic Review
- Comparison of Efficacy and Safety of Cinacalcet Versus Calcitriol in Patients of Secondary Hyperparathyroidism in Indian Population
- Product Monograph
- SENSIPAR® (Cinacalcet) Tablets, for Oral Use Hypocalcemia: Life Threatening Events and Fatal Outcomes Were Initial US Approval: 2004 Reported
- SENSIPAR (Cinacalcet) RATIONALE for INCLUSION in PA PROGRAM
- Pharmacoeconomic Evaluation of Antibiotic Therapy of Community
- Mclaren Health Plan Medicaid Prior Authorization Guidelines
- Parsabiv™ (Etelcalcetide)
- Teriparatide Treatment in a Heart Transplant Patient with a Chronic Kidney Disease and a Low-Turnover Bone Disease: Acasereport
- Article Conversion from Intravenous Vitamin D Analogs to Oral Calcitriol
- ATC-Index Mit DDD-Angaben Für Deutschland Im Jahre 2019
- Calcimimetic (Cinacalcet, Etelcalcetide) Criteria for Use January 2018
- Effect of Etelcalcetide Vs Cinacalcet on Serum Parathyroid Hormone in Patients Receiving Hemodialysis with Secondary Hyperparathyroidism a Randomized Clinical Trial
- 2305.Full.Pdf
- Cinacalcet for Secondary Hyperparathyroidism: from Improved Mineral Levels to Improved Mortality?